Rotigotine patches (Neupro) in early Parkinson’s disease

Rotigotine patches (Neupro) in early Parkinson’s disease

Parkinson’s disease (PD) is a neurodegenerative disorder secondary to the progressive loss of dopaminergic neurons in the substantia nigra (a portion of the midbrain responsible for movement initiation and coordination) and appearance of bradykinesia, resting tremor, rigidity and postural reflex imp...

Full description

Bibliographic Details
Main Author:	Viola Sacchi
Format:	Article
Language:	English
Published:	SEEd Medical Publishers 2008-06-01
Series:	Farmeconomia: Health Economics and Therapeutic Pathways
Online Access:	https://journals.seedmedicalpublishers.com/index.php/FE/article/view/223

Similar Items

Rotigotine transdermal patch in Parkinson's disease: a systematic review and meta-analysis.
by: Chang-Qing Zhou, et al.
Published: (2013-01-01)

Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
by: Kim Han-Joon, et al.
Published: (2011-08-01)

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
by: Philipp Spitzer, et al.
Published: (2010-01-01)

The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease
by: Marina Romanovna Nodel
Published: (2013-11-01)

A Study for Expanding Application Sites for Rotigotine Transdermal Patch
by: Hitoshi Kujirai, et al.
Published: (2020-01-01)

Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson’s Disease
by: Francesc Vallderiola, et al.
Published: (2015-01-01)

BEHAVIORAL AND NEUROPHYSIOLOGICAL EFFECTS OF TRANSDERMAL ROTIGOTINE IN ATYPICAL PARKINSONISM
by: Davide v Moretti, et al.
Published: (2014-06-01)

Preparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson’s disease and its evolution study
by: Aiping Wang, et al.
Published: (2016-05-01)

Safety and Efficacy of Rotigotine for Treating Parkinson’s Disease: A Meta-Analysis of Randomised Controlled Trials
by: Fei Chen, et al.
Published: (2017-08-01)

Rotigotine Objectively Improves Sleep in Parkinson’s Disease: An Open-Label Pilot Study with Actigraphic Recording
by: Giovanna Calandra-Buonaura, et al.
Published: (2016-01-01)

Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson’s Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study
by: Javier Pagonabarraga, et al.
Published: (2015-01-01)

Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
by: Bi CC, et al.
Published: (2016-12-01)

Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch
by: Trenkwalder Claudia, et al.
Published: (2010-09-01)

Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both a-synucleinopathy and tauopathy
by: Moretti DV, et al.
Published: (2014-06-01)

Preventive effect of a heparinoid-containing product on the application site reaction of the rotigotine transdermal patch in Parkinson’s disease: A pilot randomized clinical trial (the SkinHeRo study)
by: Jinsoo Koh, et al.
Published: (2021-01-01)

The use of rotigotine in the treatment of restless legs syndrome
by: Anna Serafini, et al.
Published: (2010-07-01)

Restless legs syndrome: differential diagnosis and management with rotigotine
by: Giovanni Merlino, et al.
Published: (2009-01-01)

Transdermal rotigotine for the perioperative management of restless legs syndrome
by: Högl Birgit, et al.
Published: (2012-09-01)

Efficacy of transdermal rotigotine in chronic cluster headache: A case series
by: Cherubino Di Lorenzo, et al.
Published: (2018-11-01)

The Effect of Rotigotine Extended-Release Microspheres Alone or With Celecoxib on the Inflammatory Pain
by: Keke Li, et al.
Published: (2020-10-01)

Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery
by: Angeline Shak. Tzeyung, et al.
Published: (2019-01-01)

Rotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 Cases
by: Jana Godau, et al.
Published: (2011-01-01)

Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies
by: Wang Z, et al.
Published: (2015-01-01)

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
by: A. Castrioto, et al.
Published: (2020-12-01)

The efficacy and tolerability of rotigotine on patients with periodic limb movement in sleep: A systematic review and meta-analysis.
by: Meng-Ni Wu, et al.
Published: (2018-01-01)

Effects of rotigotine on clinical symptoms, quality of life and sleep hygiene adequacy in hemodialysis-associated restless legs syndrome
by: Vicent Esteve, et al.
Published: (2018-01-01)

USE OF A RIVASTIGMINE TRANSDERMIC PATCH IN ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE DEMENTIA
by: Lacramioara Perju Dumbrava, et al.
Published: (2009-03-01)

Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease
by: Yaozhen Wang, et al.
Published: (2018-09-01)

Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects
by: Yan X, et al.
Published: (2018-01-01)

Dysarthria in early Parkinson's disease
by: Konstantopoulos, Konstantinos
Published: (2004)

Early Stage Detection of Parkinson Disease
by: Navada Megha, et al.
Published: (2021-01-01)

Centrality of Early Synaptopathy in Parkinson’s Disease
by: Paola Imbriani, et al.
Published: (2018-03-01)

Biomarkers in the early diagnosis of Parkinson's disease
by: Qian SUN, et al.
Published: (2013-08-01)

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
by: B. R. Bloem, et al.
Published: (2019-07-01)

Apathy and Olfactory Dysfunction in Early Parkinson’s Disease
by: Jin Yong Hong, et al.
Published: (2015-01-01)

ParkDetect - Early Diagnosing Parkinsons Disease
by: Ricardo Graça
Published: (2014)

Autonomic dysfunction in early and advanced Parkinson's disease
by: Pursiainen, V. (Ville)
Published: (2007)

Executive functioning in early stage Parkinson's disease
by: Kudlicka, Aleksandra Katarzyna
Published: (2013)

Social Cognition in Patients with Early-Onset Parkinson’s Disease
by: Ana Natalia Seubert-Ravelo, et al.
Published: (2021-01-01)

Review: Improving symptom control in early Parkinson’s disease
by: Stuart H. Isaacson, et al.
Published: (2009-11-01)

Cannot write session to /tmp/vufind_sessions/sess_8h2rr33ere2ebvd9onb9ojut6d